Drugs / GCflu
GCflu
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT02723812 | Nov → Dec 2015 | influenza | Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products | Completed | No outcome recorded |
| Phase 4 | NCT02067117 | Oct → Nov 2010 | — | Green Cross Corporation | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT02352584 Comparator | Oct → Dec 2014 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Phase 4 | NCT02582047 Comparator | Oct → Dec 2012 | influenza, pneumococcal infection | Korea University Guro Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCFLU | “GCflu and Pneumovax-23” NCT02582047 ↗ |
| Known as | GC FLU Injection | “GC FLU® Injection, GC FLU® Pre-filled Syringe Injection” NCT02067117 ↗ |
| Known as | GC FLU Pre-filled Syringe Injection | “GC FLU® Injection, GC FLU® Pre-filled Syringe Injection” NCT02067117 ↗ |